Chair Appointment: Alliance Program for Procedure-Based Therapy
February 13, 2023
The Alliance Board of Directors is pleased to announce the appointment of Isabelle Bedrosian, MD, to the position of Director of the Alliance Program for Procedure-Based Therapy. Dr. Bedrosian is the Medical Director of the Nellie B. Connally Breast Center and Professor of Breast Surgical Oncology at The University of Texas MD Anderson Cancer Center.
Dr. Bedrosian has a long history of success and engagement in Alliance, serving and as the Chair and developing the Breast Local Regional Working Group and most recently, serving as co-chair of the Alliance Prevention Committee. She brings many years of experience as a breast surgical oncologist to the newly formed Program for Procedure-Based Therapy, where she will oversee the development of this novel program aiming to develop innovations in surgery, radiation oncology, interventional radiology, interventional medical specialties, and medical devices in order to improve outcomes for cancer patients.
The Alliance is thankful to the entire search committee for their efforts in this successful search.
Learn more about Dr. Bedrosian’s research here.
Related Posts
Combo Extends OS in Patients 65+ with Ph+ ALL
Long-term results show combination treatment that skips chemotherapy is effective for older patients with Ph+ ALL
Model Predicts AI Non-adherence Risk
A new risk model uses baseline sociodemographic and financial measures to predict which patients prescribed long-term therapy with aromatase inhibitors for breast cancer are at significantly higher risk of stopping that therapy early
ECOG-ACRIN and PrECOG announce multiple presentations at ASH 2023
Researchers with the ECOG-ACRIN Cancer Research Group and PrECOG, LLC will present six oral and three poster presentations at the 65th American Society of Hematology Meeting & Exposition